Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated Statements of Comprehensive Loss

v3.20.1
Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Consolidated Statements of Comprehensive Loss [Abstract]      
Revenues $ 2,032 $ 3,820 $ 789
Research and development expenses (10,976) (6,075) (5,106)
General and administrative expenses (3,059) (3,159) (2,868)
Operating loss (12,003) (5,414) (7,185)
Other income 769
Financial expenses (693) (1,204) (621)
Financial income 3,109 51 633
Total Financial income (expense), net 2,416 (1,153) 12
Loss before taxes on income (9,587) (6,567) (6,404)
Taxes on income (4) (29)
Net loss (9,587) (6,571) (6,433)
Amounts that will not be reclassified subsequently to profit or loss:      
Adjustment arising from translating financial statements from functional currency to presentation currency 636
Total other comprehensive loss 636
Total comprehensive loss (9,587) (6,571) (5,797)
Net loss Attributable to:      
Equity holders of the Company (9,587) (6,571) (6,339)
Non-controlling interests (94)
Net loss (9,587) (6,571) (6,433)
Total comprehensive loss attributable to:      
Equity holders of the Company (9,587) (6,571) (5,703)
Non-controlling interests (94)
Total comprehensive loss $ (9,587) $ (6,571) $ (5,797)
Net loss per share attributable to equity holders of the Company:      
Basic and diluted net loss per share $ (0.11) $ (0.17) $ (0.19)